What we do

Four capabilities, built to work together

Most partners in this market do one of these things. The value is in holding all four.

The connected care ecosystem

A scientific representative and hospital clinician discussing specialty medicine access

Connected expertise

Scientific office and in-country representation

We act as the commercial and scientific presence in Nigeria for manufacturers who need one without establishing their own operation here. That means local market intelligence, engagement with the stakeholders who matter, coordination with regulatory and commercial partners, pharmacovigilance, and continuous representation of your interests in the market.

What this means for you

For international pharmaceutical manufacturers and healthcare product owners, the outcome is a trusted local presence without the cost and exposure of a Nigerian subsidiary.

Discuss this capability →
A pharmacist checking medicine supplies in a modern pharmaceutical distribution centre

Connected expertise

Importation and distribution

We coordinate compliant importation and create dependable channels that move medicines efficiently from manufacturers through qualified partners to healthcare providers. That covers import coordination, product supply, channel management, and access to hospitals, clinics and retail pharmacies.

What this means for you

For manufacturers and product owners who need reliable movement of goods, the outcome is a product that travels from manufacturer to market without compromise, including the last mile.

Discuss this capability →
Healthcare professionals participating in a scientific market access meeting

Connected expertise

Marketing, promotion, brand management and market access

We build demand through scientific engagement, key opinion leader relationships and targeted market development. That includes market assessment, brand strategy, promotional activity, capability building and training, route-to-market planning and market access support.

What this means for you

For manufacturers with innovative or specialty products entering a market they do not yet know well, the outcome is stronger positioning, genuine clinician engagement and commercial performance that can be measured.

Discuss this capability →
Pharmaceutical compliance advisers reviewing quality documentation

Connected expertise

Consulting services

We provide advisory support for the regulatory, safety, quality and commercial obligations that come with introducing a medicine to a new market. That includes pharmacovigilance coordination, compliance support and go-to-market advice for organisations entering or expanding in Nigeria.

What this means for you

For manufacturers, healthcare companies and organisations who anticipate these obligations, the outcome is regulatory readiness, demonstrable compliance and better commercial decisions.

Discuss this capability →

Your next connection

Let’s build your
presence in Nigeria.

Start a conversation